{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Glucan 1,3-beta-glucosidase : Questions médicales les plus fréquentes",
"headline": "Glucan 1,3-beta-glucosidase : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Glucan 1,3-beta-glucosidase : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-18",
"dateModified": "2025-02-12",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Glucan 1,3-beta-glucosidase"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Cellulases",
"url": "https://questionsmedicales.fr/mesh/D044602",
"about": {
"@type": "MedicalCondition",
"name": "Cellulases",
"code": {
"@type": "MedicalCode",
"code": "D044602",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.450.420.200"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Glucan 1,3-beta-glucosidase",
"alternateName": "Glucan 1,3-beta-Glucosidase",
"code": {
"@type": "MedicalCode",
"code": "D043326",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Johannes Wagener",
"url": "https://questionsmedicales.fr/author/Johannes%20Wagener",
"affiliation": {
"@type": "Organization",
"name": "Max von Pettenkofer-Institut für Hygiene und Medizinische Mikrobiologie, Ludwig-Maximilians-Universität München, Munich, Germany."
}
},
{
"@type": "Person",
"name": "Shigekazu Yano",
"url": "https://questionsmedicales.fr/author/Shigekazu%20Yano",
"affiliation": {
"@type": "Organization",
"name": "Graduate School of Sciences and Engineering, Yamagata University."
}
},
{
"@type": "Person",
"name": "Malgorzata Mikulska",
"url": "https://questionsmedicales.fr/author/Malgorzata%20Mikulska",
"affiliation": {
"@type": "Organization",
"name": "Division of Infectious Diseases, Department of Health Sciences (DISSAL), University of Genova, Genova, Italy; IRCCS Ospedale Policlinico San Martino, Genova, Italy."
}
},
{
"@type": "Person",
"name": "Malcolm Finkelman",
"url": "https://questionsmedicales.fr/author/Malcolm%20Finkelman",
"affiliation": {
"@type": "Organization",
"name": "Clinical Development, Associates of Cape Cod, Inc, Falmouth, MA, USA."
}
},
{
"@type": "Person",
"name": "Yonglong Zhang",
"url": "https://questionsmedicales.fr/author/Yonglong%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "Clinical Development, Associates of Cape Cod, Inc, Falmouth, MA, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Creative problem solving and facial expressions: A stage based comparison.",
"datePublished": "2022-06-22",
"url": "https://questionsmedicales.fr/article/35731723",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0269504"
}
},
{
"@type": "ScholarlyArticle",
"name": "\"If there is a tension about something, I can solve it\": A qualitative investigation of change processes in a trial of brief problem-solving interventions for common adolescent mental health problems in India.",
"datePublished": "2022-11-09",
"url": "https://questionsmedicales.fr/article/36351707",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/papt.12433"
}
},
{
"@type": "ScholarlyArticle",
"name": "Can the Effect of Problem Solvers' Characteristics on Adolescents' Cooperative Problem Solving Ability Be Improved by Group Sizes?",
"datePublished": "2022-12-09",
"url": "https://questionsmedicales.fr/article/36554453",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph192416575"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effects of Problem-Based Learning on the Problem-Solving Ability and Self-Efficacy of Students Majoring in Dental Hygiene.",
"datePublished": "2022-06-18",
"url": "https://questionsmedicales.fr/article/35742736",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph19127491"
}
},
{
"@type": "ScholarlyArticle",
"name": "Different cognitive mechanisms used for solving open and closed math problems.",
"datePublished": "2023-08-02",
"url": "https://questionsmedicales.fr/article/37533291",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/ijop.12934"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrolases",
"item": "https://questionsmedicales.fr/mesh/D006867"
},
{
"@type": "ListItem",
"position": 5,
"name": "Glycosidases",
"item": "https://questionsmedicales.fr/mesh/D006026"
},
{
"@type": "ListItem",
"position": 6,
"name": "Glucosidases",
"item": "https://questionsmedicales.fr/mesh/D005959"
},
{
"@type": "ListItem",
"position": 7,
"name": "Cellulases",
"item": "https://questionsmedicales.fr/mesh/D044602"
},
{
"@type": "ListItem",
"position": 8,
"name": "Glucan 1,3-beta-glucosidase",
"item": "https://questionsmedicales.fr/mesh/D043326"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Glucan 1,3-beta-glucosidase - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Glucan 1,3-beta-glucosidase",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Glucan 1,3-beta-glucosidase",
"description": "Comment diagnostiquer une déficience en glucan 1,3-beta-glucosidase ?\nQuels tests sont utilisés pour mesurer l'activité de l'enzyme ?\nQuels symptômes peuvent indiquer un problème avec cette enzyme ?\nY a-t-il des marqueurs biologiques associés à cette enzyme ?\nComment les tests génétiques aident-ils au diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D043326?mesh_terms=Problem+Solving&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Glucan 1,3-beta-glucosidase",
"description": "Quels sont les symptômes d'une déficience en glucan 1,3-beta-glucosidase ?\nLa déficience peut-elle causer des problèmes immunitaires ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes varient-ils selon l'âge ?\nLes symptômes sont-ils réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D043326?mesh_terms=Problem+Solving&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Glucan 1,3-beta-glucosidase",
"description": "Peut-on prévenir la déficience en glucan 1,3-beta-glucosidase ?\nY a-t-il des mesures préventives pour les symptômes ?\nLes tests génétiques peuvent-ils aider à la prévention ?\nL'éducation des patients est-elle importante ?\nLes conseils diététiques peuvent-ils prévenir des complications ?",
"url": "https://questionsmedicales.fr/mesh/D043326?mesh_terms=Problem+Solving&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Glucan 1,3-beta-glucosidase",
"description": "Quels traitements existent pour la déficience en glucan 1,3-beta-glucosidase ?\nLes médicaments peuvent-ils aider à gérer les symptômes ?\nY a-t-il des thérapies alternatives recommandées ?\nLa diététique joue-t-elle un rôle dans le traitement ?\nDes traitements expérimentaux sont-ils disponibles ?",
"url": "https://questionsmedicales.fr/mesh/D043326?mesh_terms=Problem+Solving&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Glucan 1,3-beta-glucosidase",
"description": "Quelles complications peuvent survenir avec cette déficience ?\nLa déficience peut-elle entraîner des infections fréquentes ?\nY a-t-il des risques de complications à long terme ?\nLes complications peuvent-elles être évitées ?\nLes complications affectent-elles la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D043326?mesh_terms=Problem+Solving&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Glucan 1,3-beta-glucosidase",
"description": "Quels sont les facteurs de risque pour cette déficience ?\nL'âge joue-t-il un rôle dans le risque de déficience ?\nLes facteurs environnementaux influencent-ils le risque ?\nLes antécédents médicaux augmentent-ils le risque ?\nLes facteurs socio-économiques influencent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D043326?mesh_terms=Problem+Solving&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en glucan 1,3-beta-glucosidase ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic se fait par des tests enzymatiques et des analyses génétiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour mesurer l'activité de l'enzyme ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests biochimiques spécifiques mesurent l'activité de la glucan 1,3-beta-glucosidase dans les échantillons."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème avec cette enzyme ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fatigue, des douleurs abdominales ou des troubles digestifs peuvent survenir."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs biologiques associés à cette enzyme ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux anormaux de glucanes dans le sang peuvent servir de marqueurs biologiques."
}
},
{
"@type": "Question",
"name": "Comment les tests génétiques aident-ils au diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils identifient des mutations spécifiques dans le gène codant pour l'enzyme, confirmant le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une déficience en glucan 1,3-beta-glucosidase ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, douleurs abdominales, et troubles de la digestion."
}
},
{
"@type": "Question",
"name": "La déficience peut-elle causer des problèmes immunitaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une déficience peut affecter le système immunitaire, augmentant la susceptibilité aux infections."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles neurologiques peuvent survenir, bien que moins fréquents, comme des maux de tête."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'âge et de la gravité de la déficience."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils réversibles ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains symptômes peuvent être gérés, mais la déficience elle-même est généralement permanente."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la déficience en glucan 1,3-beta-glucosidase ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La déficience est généralement génétique, donc la prévention n'est pas possible."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures préventives pour les symptômes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des modifications alimentaires et un suivi médical régulier peuvent aider à gérer les symptômes."
}
},
{
"@type": "Question",
"name": "Les tests génétiques peuvent-ils aider à la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent identifier les porteurs et informer sur les risques."
}
},
{
"@type": "Question",
"name": "L'éducation des patients est-elle importante ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation sur la maladie et ses symptômes est cruciale pour une gestion efficace."
}
},
{
"@type": "Question",
"name": "Les conseils diététiques peuvent-ils prévenir des complications ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conseils diététiques appropriés peuvent aider à prévenir des complications digestives."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour la déficience en glucan 1,3-beta-glucosidase ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure des suppléments enzymatiques et des modifications alimentaires."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider à gérer les symptômes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments peuvent être prescrits pour soulager les symptômes digestifs et la douleur."
}
},
{
"@type": "Question",
"name": "Y a-t-il des thérapies alternatives recommandées ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines thérapies alternatives, comme la phytothérapie, peuvent être envisagées, mais avec prudence."
}
},
{
"@type": "Question",
"name": "La diététique joue-t-elle un rôle dans le traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation adaptée peut aider à réduire les symptômes et améliorer la qualité de vie."
}
},
{
"@type": "Question",
"name": "Des traitements expérimentaux sont-ils disponibles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches sont en cours sur des traitements expérimentaux, mais ils ne sont pas encore largement disponibles."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec cette déficience ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications digestives, immunitaires et neurologiques peuvent se développer."
}
},
{
"@type": "Question",
"name": "La déficience peut-elle entraîner des infections fréquentes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une déficience en glucan 1,3-beta-glucosidase peut augmenter le risque d'infections."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de complications à long terme ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications à long terme peuvent inclure des troubles digestifs chroniques et des infections récurrentes."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être évitées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être évitées par une gestion proactive des symptômes."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement affecter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour cette déficience ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs de risque incluent des antécédents familiaux et des mutations génétiques spécifiques."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans le risque de déficience ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge peut influencer l'apparition des symptômes, mais la déficience est généralement génétique."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux influencent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'y a pas de preuves solides que les facteurs environnementaux influencent ce risque."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antécédents médicaux de troubles digestifs peuvent augmenter la suspicion de déficience."
}
},
{
"@type": "Question",
"name": "Les facteurs socio-économiques influencent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs socio-économiques peuvent affecter l'accès aux soins, mais pas directement le risque génétique."
}
}
]
}
]
}
A wealth of research indicates that emotions play an instrumental role in creative problem-solving. However, most of these studies have relied primarily on diary studies and self-report scales when me...
There is limited understanding of change processes and long-term effects of low-intensity psychosocial interventions. We investigated these aspects in two brief problem-solving intervention formats fo...
This qualitative study was nested within a school-based randomized controlled trial in New Delhi, India, which compared two problem-solving intervention formats: a lay counsellor-led format supported ...
Five themes were derived using thematic framework analysis. The "impacts on symptoms and functioning" theme described symptomatic improvements and functional gains. "Processes underlying problem solvi...
We infer from our qualitative analysis that changes in problem-solving style and problem orientation underpinned long-term symptomatic and functional improvements. Participants in the counsellor-led i...
Cooperative problem solving (CPS) is an essential ability in people's daily life. When individuals with different problem-solvers' characteristics (orientation and style) are assigned to different gro...
This study developed a problem-based learning (PBL) module to improve integrated thinking and problem-solving ability in students of dental hygiene. After applying PBL, the study tested the improvemen...
Problem-solving skills are very important in our daily life. Almost all problem-solving studies have addressed the cognitive correlates of solving closed problems, but only limited studies have invest...
To effectively realise their role in health promotion nurses need a clear understanding of the social determinants of health. In 1987 the WHO recommended that students participate in meaningful commun...
To explore the use of community problem-solving in undergraduate nurse education and its impact on students' understanding of population health....
This literature review used a five-stage iterative method, to explore the following research question; how is community problem-solving being used in undergraduate nurse education and to what effect? ...
Ten studies were identified which explore the use of community problem-solving these provide some useful insight into the design, application and the apparent benefits of the approach in undergraduate...
The concept of CPS in undergraduate nurse education has been around for many years, but there has never been a comprehensive review of its implementation or effectiveness. Research into its impact is ...
This article concerns with terminal recurrent neural network (RNN) models for time-variant computing, featuring finite-valued activation functions (AFs), and finite-time convergence of error variables...
The current study sought to tease apart the unique contributions of napping and nighttime sleep to infant learning, specifically in the context of motor problem solving. We challenged 54 walking infan...
In forensic science, scientific problem-solving is characterized by the recognition of traces as part of iterative reasoning processes to assign meaning to those traces in order to interpret and recon...
Stroke has been associated with sociocognitive impairment, so far well documented for emotion recognition and Theory of Mind. However, more complex abilities, such as social problem solving, which dir...
The present study aimed to address this gap by focusing on performance-based social problem solving abilities and self-reported socioemotional abilities (i.e., empathy and alexithymia) in outpatient s...
In the main analyses, patients were impaired in their ability to freely generate appropriate solutions for challenging interpersonal situations depicted in written scenarios but performed on a compara...
The present results suggest that stroke is associated with a broad impact on socioemotional and social problem solving abilities. As difficulties in social problem solving might be associated with inc...